Weave

Weave

Biotechnology Research

Weave together thousands of pages of source documents and accelerate your IND submission

About us

Weave Bio is an AI-native, life sciences platform company that provides a technically robust, AI-enabled platform for major pain points inherent in the pharma and biotech industries. Our flagship product, AutoIND, is the first offering on Weave’s comprehensive Regulatory Automation and Lifecycle Management (ReALM) platform. With AutoIND we streamline the Investigational New Drug (IND) application process and enable drug development teams to build a living record of their therapeutic candidates, delivering significant improvements in both efficiency and quality. AutoIND automatically generates content based on users’ own source data, regulatory guidelines, and public information. The solution offers a robust, in-platform process for quality review and significantly enhances editing capabilities and oversight for teams. While conventional IND preparation processes can take more than a year, AutoIND can produce a first draft of an IND in a single day and reduce the overall time to generate a final IND submission by over 50%, returning capacity to regulatory teams, lowering costs, and ultimately accelerating the time it takes to get treatments to patients. For more information, visit weave.bio

Website
https://www.weave.bio/
Industry
Biotechnology Research
Company size
11-50 employees
Type
Privately Held
Founded
2023

Employees at Weave

Updates

Similar pages

Funding

Weave 3 total rounds

Last Round

Seed

US$ 10.0M

See more info on crunchbase